Basic fibroblast growth factor: a potential therapeutic agent for the treatment of acute neurodegenerative disorders and vascular insufficiency

Bibliography

• KLAGSBRUN M, D'AMORE PA: Regulators of angiogenesis. Ann. Rev. Physic)]. (1991) 53:217–39.
   PubMed Web of Science ®Google Scholar
• •Comprehensive review of modulators of angiogenesis.
   Google Scholar
• NIKOLICS K, HEFTI F, THOMAS GR, GLUCKMAN PD: Trophic factors and their role in the postischemic brain. Adv. Neurol. (1996) 71:389–403.
   PubMedGoogle Scholar
• •Comprehensive review describing neurotrophic factors as potential therapeutic agents.
   Google Scholar
• HAGG T: Neurotrophic factors. In: CNS Injuries: Cellular Responses and Pharmacological Strategies. Berry M, Logan A (Eds.), CRC Press, Boca Raton (1998):169–200.
   Google Scholar
• GAO W-Q, WEIL RJ, DUGICH-DJORDJEVIC M, LU B: The therapeutic potentials of neurotrophic factors for dis-eases of the nervous system. Exp. Opin. Ther. Patents (1997) 7 (4) :325–338.
   Google Scholar
• GOSPODAROWICZ D: Biological activities of fibroblast growth factors. Ann. NY Acad. Sci. (1991) 638:1–8.
   PubMedGoogle Scholar
• ECKENSTEIN FP: Fibroblast growth factors in the nerv-ous system. J. Neurobiol (1994) 25(10:1467–1480.
   PubMedGoogle Scholar
• •Extensive review of the effects of bFGF in the CNS.
   Google Scholar
• GALZIE Z, KINSELLA AR, SMITH JA: Fibroblast growth factors and their receptors. Biochem. Cell Biol. (1997) 75 (6):669–685.
   PubMedGoogle Scholar
• •Recent description of emerging FGF family members.
   Google Scholar
• GROTHE C, MEISINGER C, WEWETZER K: Fibroblast growth factors. In: CNS Injuries: Cellular Responses and Pharmacological Strategies. Berry M, Logan A (Eds.), CRC Press, Boca Raton (1998):201–218.
   Google Scholar
• ••Excellent and concise overview of bFGF and CNS cellularinjury.
   Google Scholar
• MCKEEHAN WL, WANG F, KAN M: The heparan sulfate-fibroblast growth factor family: diversity of structure and function. Prog. Nucleic Add Res. Mol. Biol (1998) 59:135–176.
   PubMed Web of Science ®Google Scholar
• •Most recent review of FGF super family.
   Google Scholar
• ORNITZ DM, XU, J, COLVIN JS et al.: Receptor specificity of the fibroblast growth factor family. J. Biol. Chem. (1996) 271:15292–15297.
   PubMedGoogle Scholar
• ORTEGA S, ITTMANN M, TSANG SH, EHRLICH M, BA-SILICO C: Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2. Proc. Natl. Acad. Sci. USA (1998) 95(10):5672–5677.
   PubMed Web of Science ®Google Scholar
• •Demonstrates regulation for FGFs in most tissues during morphogenesis, but implies role for bFGF in brain development.
   Google Scholar
• RAY J, BAIRD A, GAGE FH: A 10-amino acid sequence of fibroblast growth factor 2 is sufficient for its mitogenic activity on neural progenitor cells. Proc. Natl. Acad. Sci. USA (1997) 94(13):7047–7052.
   PubMedGoogle Scholar
• •Identifies small consensus sequence sufficient for bFGF ligand activity. Similar studies may develop pharmacologi-cal activities for bFGF receptors with receptor binding specificity.
   Google Scholar
• CREUZET C, LOEB J, BARBIN G: Fibroblast growth fac-tors stimulate protein tyrosine phosphorylation and mitogen-activated protein kinase activity in primary cultures of hippocampal neurons. J. Neurochem. (1995) 64 (4) :1541–1547.
   PubMedGoogle Scholar
• KUO WL, CHUNG KC, ROSNER MR: Differentiation ofcentral nervous system neuronal cells by fibroblast-derived growth factor requires at least two signaling pathways: roles for Ras and Src. Mol. Cell Biol. (1997) 17(8):4633–4643.
   PubMed Web of Science ®Google Scholar
• KOUHARA H, HADARI YR, SPIVAK-KROIZMAN T et al. A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling path-way. Cell (1997) 89(5):693–702.
   PubMed Web of Science ®Google Scholar
• PENG X, GREENE LA, KAPLAN DR, STEPHENS RM: Dele-tion of a conserved juxtamembrane sequence in Trk abolishes NGF-promoted neuritogenesis. Neuron (1995) 15(2):395–406.
   PubMedGoogle Scholar
• SPIVAK-KROIZMAN T, MOHAMMADI M, HU P et al.: Pointmutation in the fibroblast growth factor receptor eliminates phosphatidylinositol hydrolysis without affecting neuronal differentiation of PC12 cells. J. Biol. Chem. (1994) 269(20):14419–14423.
   PubMedGoogle Scholar
• CHUNG KC, GOMES I, WANG D, LAU LF, ROSNER MR: Raf and fibroblast growth factor phosphorylate Elkl and activate the serum response element of the immediate early gene pip92 by mitogen-activated protein kinase-independent as well as -dependent signaling path-ways. Mol. Cell Biol. (1998) 18(4):2272–2281.
   PubMedGoogle Scholar
• XIA Z, DICKENS M, RAINGEAUD J, DAVIS RJ, GREENBERG ME: Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science (1995) 270(5240:1326–1331.
   PubMed Web of Science ®Google Scholar
• ••Functional demonstration of antagonistic interplay betweenseparate branches of MAPK signalling pathway.
   Google Scholar
• YANG DD, KUAN CY, WHITMARSH AJ et al.: Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature (1997) 389(6653)865–870.
   Google Scholar
• ••A compelling demonstration of the role of JNK3 in kainate-induced seizure by gene knock-out.
   Google Scholar
• CLERK A, FULLER SJ, MICHAEL A, SUGDEN PH: Stimula-tion of 'stress-regulated' mitogen-activated protein ki-nases (stress-activated protein kinases/c-Jun N-terminal kinases and p38-mitogen-activated protein kinases) in perfused rat hearts by oxidative and other stresses. J. Biol. Chem. (1998) 273(13):7228–7234.
   PubMedGoogle Scholar
• YUE TL, WANG C, ROMANIC AM et al.: Staurosporine-induced apoptosis in cardiomyocytes: a potential role of caspase-3. j Mol Cell Cardiol (1998) 30(3)495–507.
   Google Scholar
• LAZOU A, SUGDEN PH, CLERK A: Activation of mitogen-activated protein kinases (p38-MAPKs, SAPKs/JNKs and ERKs) by the G-protein-coupled receptor agonist phenylephrine in the perfused rat heart. Biochem. (1998) 332(2):459–465.
   Google Scholar
• MIZUKAMI Y, YOSHIOKA K, MORIMOTO S, YOSHIDA KI: A novel mechanism of JNK1 activation. Nuclear trans-location and activation of JNK1 during ischemia and reperfusion. J. Biol. Chem. (1997) 272(26):16657–16662.
   Google Scholar
• WANG X, MARTINDALE JL, LIU Y, HOLBROOK NJ: The cel-lular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival. Biochem. J. (1998) 333(2)291–300.
   Google Scholar
• HOLMSTROM TH, CHOW SC, ELO I et al.: Suppression of Fas/AP0-1-mediated apoptosis by mitogen-activated kinase signaling. J. Immunol (1998) 160(6)2626–2636.
   Google Scholar
• HARTFIELD PJ, BILNEY AJ, MURRAY AW: Neurotrophic factors prevent ceramide-induced apoptosis down-stream of c-Jun N-terminal kinase activation in PC12 cells. J. Neurochem. (1998) 71(0:161–169.
   PubMedGoogle Scholar
• SCHEID MP, DURONIO V: Dissociation of cytokine-induced phosphorylation of Bad and activation of PKB/akt: involvement of MEK upstream of Bad phos-phorylation. Proc. Natl. Acad. Sci. USA (1998) 95(13)7439–7444.
   Google Scholar
• ALLSOPP TE, KISELEV S, WYATT S, DAVIES AM: Role of Bc1-2 in the brain-derived neurotrophic factor survival response. Eur.J. Neurosci. (1995) 7(6):1266–1272.
   PubMedGoogle Scholar
• KARSAN A, YEE E, POIRIER GG et al.: Fibroblast growth factor-2 inhibits endothelial cell apoptosis by Bc1-2-dependent and independent mechanisms. Am. J. Pa-thol (1997) 151(6):1775–1784.
   PubMedGoogle Scholar
• WEI H, WEI W, BREDESEN DE, PERRY DC: Bc1-2 protects against apoptosis in neuronal cell line caused by thapsigargin-induced depletion of intracellular cal-cium stores. Neurochem. (1998) 70 (6) :2305–2314.
   PubMedGoogle Scholar
• MATTSON MP, MURRAIN M, GUTHRIE PB, KATER SB: Fi-broblast growth factor and glutamate: opposing roles in the generation and degeneration of hippocampal neuroarchitecture. j Neurosci. (1989) 9:3728–3740.
   PubMed Web of Science ®Google Scholar
• •Report providing evidence for transcriptional regulation of bFGF-mediated survival.
   Google Scholar
• DERIJARD B, HIBI M, WU IH etal.: JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phos-phorylates the c-Jun activation domain. Cell (1994) 76 (6): 1025–1037.
   Google Scholar
• BLOTTNER D, HERDEGEN T: Neuroprotective fibroblast growth factor Type-2 down-regulates the c-Jun tran-scription factor in axotomized sympathetic pregangli-onic neurons of adult rat. Neuroscience (1998) 82 (1):283–292.
   PubMedGoogle Scholar
• JOHNSON MR, VALENTINE C, BASILICO C, MANSUKHANI A: FGF signaling activates STAT1 and p21 and inhibits the estrogen response and proliferation of MCF-7 cells. Oncogene (1998) 16(20:2647–2656.
   PubMedGoogle Scholar
• RIVA MA, MOLTENI R, LOVATI E et al.: Cyclic AMP-dependent regulation of fibroblast growth factor-2 messenger RNA levels in rat cortical astrocytes: com-parison with fibroblast growth factor-1 and ciliary neurotrophic factor. Mol. Pharmacol (1996) 49(4)699–706.
   Google Scholar
• FENNELL M, KHAWAJA XV, COCKETT MI, WOOD A: En-hanced neuronal differentiation of NTera-2 cells ex-pressing neuronally restricted b2 adrenergic receptor. Brain Res. (1998) 799:243–249.
   PubMedGoogle Scholar
• MOFFETT J, KRATZ E, STACHOWIAK MK: Increased tyro-sine phosphorylation and novel cis-acting element mediate activation of the fibroblast growth factor-2 (FGF-2) gene by nicotinic acetylcholine receptor. New mechanism for trans-synaptic regulation of cellular development and plasticity. Brain Res. Mol Brain Res. (1998) 55 (2):293–305.
   Google Scholar
• HILBORN MD, VAILLANCOURT RR, RANE SG: Growth fac-tor receptor tyrosine kinases acutely regulate neuronal sodium channels through the src signaling pathway. J. Neurosci. (1998) 18(2):590–600.
   PubMedGoogle Scholar
• MERLE PL, USSON Y, ROBERT-NICOUD M, VERDETTI J: Basic FGF enhances calcium permeable channel open-ings in adult rat cardiac myocytes: implication in the bFGF-induced increase of free Ca2+ content. Mol. Cell Cardiol (1997) 29(102687–2698.
   Google Scholar
• MERLE PL, FEIGE JJ, VERDETTI J: Basic fibroblast growth factor activates calcium channels in neonatal rat car-diomyocytes. J. Biol. Chem. (1995) 270(29) :17361–17367.
   PubMedGoogle Scholar
• SHITAKA Y, MATSUKI N, SAITO H, KATSUKI H: Basic fi-broblast growth factor increases functional L-type Ca2+ channels in fetal rat hippocampal neurons: impli-cations for neurite morphogenesis in vitro. Neurosci-ence (1996) 16(206476–6489.
   Google Scholar
• DISTASI C, MUNARON L, LAEZZA F, LOVISOLO D: Basic fi-broblast growth factor opens calcium-permeable channels in quail mesencephalic neural crest neu-rons. Eur.J. Neurosci. (1995) 7 (3) :516–520.
   PubMedGoogle Scholar
• PURO DG: A calcium-activated, calcium-permeable ion channel in human retinal glial cells: modulation by ba-sic fibroblast growth factor. Brain Res. (1991) 548(1-2) 329–333.
   PubMedGoogle Scholar
• WILLIAMS EJ, FURNESS J, WALSH FS, DOHERTY P: Char-acterisation of the second messenger pathway under-lying neurite outgrowth stimulated by FGF. Development (1994) 120 (6) :1685–1693.
   PubMedGoogle Scholar
• MUNARON L, ANTONIOTTI S, DISTASI C, LOVISOLO D: Arachidonic acid mediates calcium influx induced by basic fibroblast growth factor in Balb-c 3T3 fibroblasts. Cell Calcium (1997) 22 (3) :179–188.
   PubMedGoogle Scholar
• NICOTERA P, ORRENIUS S: The role of calcium in apop-tosis. Cell Calcium (1998) 23 (2-3) :173–180.
   PubMedGoogle Scholar
• BENEVISTE H: The excitotoxic hypothesis in relation to cerebral ischemia. Cerebravasc. Brain Metab. (1991) 3:213–145.
   PubMedGoogle Scholar
• LIPTON SA, ROSENBERG PA: Mechanisms of disease. Ex-citatory amino acids as a final common pathway for neurologic disorders. New Engl. J. Med. (1994) 330:613–622.
   Google Scholar
• •A review of evidence supporting excitotoxic mechanisms in neurodegeneration.
   Google Scholar
• ROTHMAN SM, OLNEY JW: Excitotoxicity and the NMDA receptor. Trends Neurosci. (1987) 10:299–302.
   Web of Science ®Google Scholar
• CHOI D: Ionic dependence of glutamate neurotoxicity. Neurosci. (1987) 7:369–379.
   PubMed Web of Science ®Google Scholar
• •Report defining the role of calcium in excitotoxic cell death.
   Google Scholar
• MORRISON RS, SHARMA A, DEVELLIS J, BRADSHAW RA: Basic fibroblast growth factor supports the survival of cerebral cortical neurons in primary culture. Proc. Natl. Acad. ScL (1986) 83:7537–7541.
   PubMed Web of Science ®Google Scholar
• ••First report of bFGF effect on neuronal survival in vitro.
   Google Scholar
• FINKLESTEIN SP, KEMMOU A, CADAY CG, BERLOVE DJ:Basic fibroblast growth factor protects cerebrocortical neurons against excitatory amino acid toxicity in vi-tro. Stroke (1993) 24 (Suppl. I) :141–143.
   Google Scholar
• HICKS D, HEIDINGER V, MOHAND-SAID S, SAHEL J,DREYFUS H: Growth factors and gangliosides as neuro-protective agents in excitotoxicity and ischemia. Gen. Pharmac. (1998) 30(3):265–273.
   PubMedGoogle Scholar
• FREESE A, FINKLESTEIN SP, DIFIGLIA M: Basic fibroblastgrowth factor protects striatal neurons in vitro from NMDA-receptor mediated excitotoxicity. Brain Res. (1992) 575:351–355.
   PubMedGoogle Scholar
• MATTSON MP, LOVELL MA, FURUKUWA K, MARKESBERYWR: Neurotrophic factors attenuate glutamate-induced accumulation of peroxides, elevation of intracellular Ca2+ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neu-rons. J. Neurochem. (1995) 65:1740–1751.
   PubMed Web of Science ®Google Scholar
• MATTSON MP, KUMAR KN, WANG H, CHENG B, MI-CHAELIS EK: Basic FGF regulates the expression of a functional 71 kDa NMDA receptor protein that medi-ates calcium influx and neurotoxicity in hippocampal neurons. J. Neurosci. (1993) 13:4575–4588.
   PubMedGoogle Scholar
• •Report providing evidence for a selective effect of bFGF on NMDA receptor-mediated responses.
   Google Scholar
• COLLAZO, TAKAHASHI H, MCKAY RD: Cellular targets and trophic functions of neurotrophin-3 in the developing rat hippocampus. Neuron (1992) 9:643–656.
   PubMedGoogle Scholar
• MARINI AM, SPIGA G, MOCCHETTI I: Toward the devel-opment of strategies to prevent ischemic neuronal in-jury. Ann. NY Acad. Sci. (1997) 825:209–219.
   PubMedGoogle Scholar
• IWATO A, MASAP A, YAMADA K: Expression of basic fi-broblast growth factor mRNA after transient focal ischemia: comparison with expression of c-fos, c-jun, and hsp 70 mRNA. J. Neurotrauma (1997) 14:201–210.
   PubMedGoogle Scholar
• DESHPANDE SB, NISHINO H: In vitro protection of 3-nitropropionic acid-induced toxicity of astrocytes by basic fibroblast growth factor and thrombin. Brain Res. (1998) 783:28–36.
   PubMedGoogle Scholar
• •Report describing astrocytic responses to in vitro ischaemia.
   Google Scholar
• CHENG B, MATTSON MP: NGF and bFGF protect rat hip-pocampal and human cortical neurons against hypo-glycemic damage by stabilizing calcium homeostasis. Neuron (1991) 7:1031–1041.
   PubMed Web of Science ®Google Scholar
• AKANEYA Y, ENOKIDO Y, TAKAHASHI M, HATANAKA H:In vitro model of hypoxia: basic fibroblast growth fac-tor can rescue cultured CNS neurons from oxygen-deprived cell death. J. Cereb. Blood Flow Metab. (1993) 13:1029–1032.
   PubMed Web of Science ®Google Scholar
• MANELLI AM, PUTTFARCKEN PS: 0-Amyloid-induced toxicity in rat hippocampus cells: in vitro evidence for the involvement of free radicals. Brain Res. Bull. (1995) 38:569–576.
   PubMedGoogle Scholar
• MARK RJ, HENSLEY K, BUTTERFIELD DA, MATTSON MP:Amyloid 0-peptide impairs ion-motive ATPase activi-ties: evidence for a role in loss of neuronal Ca2+ ho-meostatis and cell death. J. Neurosci. (19 9 5) 15:6239-6249.
   Google Scholar
• MARK RJ, KELLER JN, KRUMAN I, MATTSON MP Basic FGF attenuates 0-peptide-induced oxidative stress, mi-tochondrial dysfunction, and impairment of Na+/K+-ATPase activity in hippocampal neurons. Brain Res. (1997) 756:205–214.
   PubMed Web of Science ®Google Scholar
• CUMMINGS BJ, SU JH, COTMAN CW: Neuritic involve-ment within bFGF immunopositive plaques of Alz-heimer's disease. Exp. Neurol (1992) 124:315–325.
   Google Scholar
• MAIESE K, BONIECE I, DEMEO D, WAGNER JA: Peptidegrowth factors protect against ischemia in culture by preventing nitric oxide toxicity. J. Neurosci. (1993) 13(7)3034–3040.
   Google Scholar
• ZHANG Y, TATSUNO T, CARNEY JM, MATTSON MP: BasicFGF, NGF, and IGEs protect hippocampal and cortical neurons against iron-induced degeneration.. J. Cereb. Blood Flow Metab. (1993) 13:378–388.
   PubMed Web of Science ®Google Scholar
• HOU J-GG, COHEN G, MYTILINEOU C: Basic fibroblastgrowth factor stimulation of glial cells protects dopa-mine neurons from 6-hydroxydopamine toxicity: in-volvement of the glutathione system. J. Neurochem. (1997) 69(1):76–83.
   PubMedGoogle Scholar
• MATTSON MP, BARGER SW: Programmed cell life: neu-roprotective signal transduction and ischemic brain injury. In: Cerebrovascular Diseases: The 19th Princeton Stroke Conference. Moskowitz MA, Caplan LR (Eds.), Butter-worth Heinemann, Newton, MA (1995):271–290.
   Google Scholar
• •Comprehensive review of authors' work on growth factor induced signalling mechanism mediating neuroprotection.
   Google Scholar
• HAIMOVITZ-FIREDMAN A, BALABAN N, MCLOUGHLIN Met al.: Protein kinase C mediates basic fibroblast growth factor protection of endothelial cells against radiation-induced apoptosis. Cancer Res. (1994) 54:2591–2597.
   Google Scholar
• SPELIOTES EK, CADAY CG, DOT etal.: Increased expres-sion of basic fibroblast growth factor (bFGF) following focal cerebral infarction in the rat. Mol. Brain Res. (1996) 39:31–42.
   Google Scholar
• LIPPOLDT A, ANDBJER B, ROSEN L et al.: Photochemi-rally induced focal cerebral ischemia in the rat: time dependent and global increase in expression of basic fibroblast growth factor mRNA. Brain Res. (1993) 625:45–56.
   PubMedGoogle Scholar
• ENDOH M, PULSINELLI WA, WAGNER JA: Transient global ischemia induces dynamic changes in the ex-pression of bFGF and the FGF receptor. Mol Brain Res. (1994) 22:76–88.
   PubMedGoogle Scholar
• SAKAGUCHI T, YAMADA K, WANAKA A et al.: Expressionof basic fibroblast growth factor receptor messenger RNA in the periinfarcted brain tissue. Rest. Neurol. Neu-rosci. (1994) 7:29–36.
   PubMedGoogle Scholar
• SHIMADA N, GRAF R, ROSNER G et al.: Ischemic flowthreshold for extracellular glutamate increase in cat cortex. J. Cereb. Blood Flow Metab. (1989) 9:603–606.
   PubMedGoogle Scholar
• SIESJO BK, BENGTSSON F: Calcium fluxes, calcium an-tagonists, and calcium-related pathology in brain ischemia, hypoglycemia and spreading depression: a unifying hypothesis. J. Cereb. Blood Flow Metab. (1989) 9:127–140.
   PubMed Web of Science ®Google Scholar
• TRAYSTMAN RJ, KIRSCH JR, KOEHLER RC: Oxygen radical mechanisms of brain injury following ischemia and reperfusion. j Appl. Physiol. (1991) 71:1185–1195.
   PubMed Web of Science ®Google Scholar
• •Comprehensive review of the role of oxygen free radical generation in the pathophysiology of ischaemia.
   Google Scholar
• LAURITZEN M, HANSEN AJ: The effect of glutamate receptor blockade on anoxic depolarization and cortical spreading depression. J. Cereb. Blood Flow Metab. (1992) 12:223–229.
   PubMed Web of Science ®Google Scholar
• MAYEVSKY A, WEISS HR: Cerebral blood flow and oxy-gen consumption in cortical spreading depression. J. Cereb. Blood Flow Metab. (1991) 11:829–836.
   PubMed Web of Science ®Google Scholar
• NAKATA N, KATO H, KOGURE K: Protective effects of ba-sic fibroblast growth factor against hippocampal neu-ronal damage following cerebral ischemia in the gerbil. Brain Res. (1993) 605:354–356.
   PubMed Web of Science ®Google Scholar
• •Description of neuroprotective effects of bFGF in a global is-chaemia model.
   Google Scholar
• NOZAKI K, FINKLESTEIN SP, BEAL MF: Basic fibroblast growth factor protects against hypoxia-ischemia and NMDA neurotoxicity in neonatal rats. J. Cereb. Blood Flow Metab. (1993) 13:221–228.
   PubMed Web of Science ®Google Scholar
• KOKETSU N, BERLOVE DJ, MOSKOWITZ MA et al.: Pre-treatment with intraventricular basic fibroblast growth factor (bFGF) decreases infarct size following focal cerebral ischemia in rats. Ann. Neurol (1994) 35:451–457.
   PubMed Web of Science ®Google Scholar
• FISHER M, MEADOWS M-E, DO T et al.: Delayed treat-ment with intravenous basic fibroblast growth factor reduces infarct size following permanent focal cere-bral ischemia in rats. J. Cereb. Blood Flow Metab. (1995) 15:953–959.
   PubMedGoogle Scholar
• •Demonstration of the neuroprotective effects of bFGF in a rat focal ischaemia model.
   Google Scholar
• TANAKA R, MIYASAKA Y, YADA K, OHVVADA T, KAMEYA T: Basic fibroblast growth factor increases regional cerebral blood flow and reduces infarct size after ex-perimental ischemia in a rat model. Stroke (1995) 26:2154–2158.
   PubMed Web of Science ®Google Scholar
• •Description of the neuroprotective effects of bFGF in a rat focal ischaemia model.
   Google Scholar
• BETHEL A, KIRSCH JR, KOEHLER RC, FINKLESTEIN SP: Intravenous basic fibroblast growth factor decreases brain injury resulting from focal ischemia in cats. Stroke (1997) 28:609–615.
   PubMed Web of Science ®Google Scholar
• •Description of the neuroprotective effects of bFGF in a cat focal ischaemia model.
   Google Scholar
• JIANG N, FINKLESTEIN SP, DO T et al.: Delayed intravenous administration of basic fibroblast growth factor (bFGF) reduces infarct volume in a model of focal cere-bral ischemia/reperfusion in the rat. J. Neurol. Sci. (1996) 139:173–179.
   PubMed Web of Science ®Google Scholar
• •Description of the neuroprotective effects of bFGF in a cat reperfusion focal ischaemia model.
   Google Scholar
• REN JM, FINKLESTEIN SP: Time window of infarct reduction by intravenous basic fibroblast growth factor in focal cerebral ischemia. Eur. J. Pharmacol (1997) 327:11–16.
   PubMed Web of Science ®Google Scholar
• •Report describing 3 h treatment window for bFGF in a focal ischaemia model.
   Google Scholar
• COCKETT MI: IDdb report for ersofermin. (August 1997):1–18.
   Google Scholar
• CUEVAS P, CARCELLER F, ORTEGA S et al.: Hypotensive activity of fibroblast growth factor. Science (1991) 254:1208–1210.
   PubMed Web of Science ®Google Scholar
• ROSENBLATT S, IRIKURA K, CADAY CG, FINKLESTEIN SP,MOSKOWITZ MA: Basic fibroblast growth factor (bFGF) dilates rat pial arterioles. J. Cereb. Blood Flow Metab. (1994) 14:70–74.
   PubMedGoogle Scholar
• HUANG Z, CHEN K, HUANG PL, FINKLESTEIN SP, MO-SKOWITZ MA: bFGF ameliorates focal ischemic injury by blood flow-independent mechanisms in eNOS mu-tant mice. Am. J. Physiol. (1996) 272:H1401–H1405.
   Google Scholar
• •Indicates vasodilation does not account for the neuroprotec-tive effects of bFGF in a focal ischaemia model.
   Google Scholar
• TATLISUMAK T, TAKANO K, CARANO RA, FISHER M: Ef-fect of basic fibroblast growth factor on experimental focal ischemia studied by diffusion-weighted and per-fusion imaging. Stroke (1996) 27:2292–2297.
   PubMedGoogle Scholar
• JORGENSEN HS, NAKAYAMA H, RAASCHOU HO et al: Outcome and time course of recovery in stroke. Part II: time course of recovery. The Copenhagen Stroke Study. Arch. Phys. Med. Rehabil (1995) 76:406–412.
   PubMed Web of Science ®Google Scholar
• LEE RG, VANDONKELAAR P: Mechanisms underlying functional recovery following stroke. Can. J. Neurol. Sci. (1995) 22:257–263.
   PubMed Web of Science ®Google Scholar
• WEILLER C, CHOLLET F, FRISTON KJ, WISE RJ,FRACKOWIAK RS: Functional reorganization of the brain in recovery from striatocapsular infarction in man. Ann. Neurol. (1992) 31:463–472.
   PubMed Web of Science ®Google Scholar
• CAO Y, DOLHABERRIAGUE L, VIKINGSTAD EM, LEVINESR, WELCH KM: Pilot study of functional MRI to assess cerebral activation of motor function after poststroke hemiparesis. Stroke (1998) 29:112–122.
   PubMed Web of Science ®Google Scholar
• CRAMER SC, NELLES G, BENSON RR et al.: A functionalMRI study of subjects recovered from hemiparetic stroke. Stroke (1997) 28:2518–2527.
   PubMed Web of Science ®Google Scholar
• JONES TA, SCHALLERT T: Use-dependent growth of py-ramidal neurons after neocortical damage. J. Neurosci. (1994) 14:2140–2152.
   PubMed Web of Science ®Google Scholar
• STROEMER RP, KENT TA, HULSEBOSCH CE: Neocortical neural sprouting, synaptogenesis, and behavioral re-covery after neocortical infarction in rats. Stroke (1995) 26:2135–2144.
   PubMed Web of Science ®Google Scholar
• HIMMELSEHER S, PFENNINGER E, GEORGIEFF M: Effects of basic fibroblast growth factor on hippocampal neu-rons after axonal injury. J. Trauma (1997) 42:659–664.
   PubMedGoogle Scholar
• OTTO D, UNSICKER K: Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice. J. Neurosci. (1990) 10:1912–1921.
   PubMed Web of Science ®Google Scholar
• YAMADA K, KINOSHITA A, KOHMURA E et al.: Basic fi-broblast growth factor prevents thalamic degenera-tion after cortical infarction. J. Cereb. Blood Flow Metab. (1991) 11:472–478.
   PubMed Web of Science ®Google Scholar
• KAWAMATA T, ALEXIS NE, DIETRICH WD, FINKLESTEIN SP: Intracisternal basic fibroblast growth factor (bFGF) enhances behavioral recovery following focal cere-bral infarction in the rat. J. Cereb. Blood Flow Metab. (1996) 16:542–547.
   PubMed Web of Science ®Google Scholar
• •First demonstration of the recovery of function effects of bFGF following delayed administration in an ischaemia model.
   Google Scholar
• KAWAMATA T, DIETRICH WD, SCHALLERT T et al.: In-tracisternal basic fibroblast growth factor enhances functional recovery and up-regulates the expression of a molecular marker of neuronal sprouting follow-ing focal cerebral infarction. Proc. Natl. Acad. Sci. USA (1997) 94:8179–8184.
   PubMed Web of Science ®Google Scholar
• YOUNG W: Secondary injury mechanisms in acute spi-nal cord injury. J. Emerging Med. (1993) 11:13–22.
   PubMedGoogle Scholar
• MCINTOSH TK: The neurochemical sequelae of trau-matic brain injury: therapeutic implications. Cerebro-vasc. Brain Metab. Rev. (1994) 6:109–162.
   PubMedGoogle Scholar
• •Excellent review of the temporal and biochemical features of brain trauma.
   Google Scholar
• IWASAKI Y, SHIOJIMA T, IKEDA K et al.: Acidic and basic fibroblast growth factors enhance neurite outgrowth in cultured rat spinal cord neurons. Neurol. Res. (1995) 17:70–72.
   PubMed Web of Science ®Google Scholar
• IWASAKI Y, SHIOJIMA T, TAGAYA N et al.: Basic fibro-blast growth factor and platelet-derived growth factor prevent the death of spinal motor neurons after sciatic nerve transection in the neonatal rats. Neurol Res. (1997) 19:555–557.
   PubMed Web of Science ®Google Scholar
• IWASHITA A, HISAJIMA H, NOTSU Y, OKUHARA M: Ef-fects of basic fibroblast growth factor and ganglioside GM1 on neuronal survival in primary cultures and on eight-arm radial maze task in adult rats following par-tial fimbria transections. Naunyn Schmied. Arch. Phar-macol. (1996) 353:342–348.
   PubMed Web of Science ®Google Scholar
• FRANK E, RAGEL B: Cortical basic fibroblast factor ex-pression after head injury: preliminary results. Neurol Res. (1995) 17:129–131.
   PubMed Web of Science ®Google Scholar
• DIETRICH WD, ALONSO O, BUSTO R, FINKLESTEIN SP: Posttreatment with intravenous basic fibroblast growth factor reduced histopathological damage fol-lowing fluid-percussion brain injury in rats. J. Neuro-trauma (1996) 13(6):309–316.
   Google Scholar
• ••First demonstration of a neuroprotective effect of bFGF inbrain trauma.
   Google Scholar
• MCDERMOTT KL, RAGHUPATHI R, FERNANDEZ SC et al.: Delayed administration of basic fibroblast growth fac-tor (bFGF) attenuates cognitive dysfunction following parasagittal fluid percussion brain injury in the rat. J. Neurotrauma (1997) 14(4):191–200.
   PubMedGoogle Scholar
• •First demonstration of a recovery of function effect of bFGF in brain trauma following delayed administration.
   Google Scholar
• HOFFMAN SW, FULOP Z, STEIN DG: Bilateral frontal cor-tical contusion in rats: behavioral and anatomic conse-quences. J. Neurotrauma (1994) 11 (4) :417–431.
   PubMedGoogle Scholar
• MOCHETTI I, RABIN SJ, COLANGELO AM, WHITTEMORE SR, WRATHALL JR: Increased basic fibroblast growth factor expression following contusive spinal cord in-jury. Exp. Neurol (1996) 141:154–164.
   PubMedGoogle Scholar
• BAFFOUR R, ACHANTA K, KAUFMAN J et al.: Synergistic effect of basic fibroblast growth factor and methyl-prednisolone on neurological function after experi-mental spinal cord injury. J. Neurosurg. (1995) 83:105–110.
   PubMed Web of Science ®Google Scholar
• •First demonstration of a functional neuroprotective effect of bFGF in spinal trauma.
   Google Scholar
• TENG YD, MOCCHETTI I, WRATHALL JR: Basic and acidic fibroblast growth factors protect spinal motor neu-rones in vivo after experimental spinal cord injury. Eur. j Neurosci. (1998) 10:798–802.
   PubMed Web of Science ®Google Scholar
• ••Comprehensive study describing the neuroprotective effectsof bFGF in spinal trauma.
   Google Scholar
• YANG HT, DESCHENES MR, OGILVIE RW, TERJUNG RL: Basic fibroblast growth factor increases collateral blood flow in rats with femoral artery ligation. Circ. Res. (1996) 79:62–69.
   PubMed Web of Science ®Google Scholar
• YANG HT, OGILVIE RW, TERJUNG RL: Exercise training enhances basic fibroblast growth factor-induced col-lateral blood flow. Am. J. Physiol. Heart Circ. Physiol. (1998) 43:H2053–H2061.
   Google Scholar
• BAFFOUR R, BERMAN J, GARB JL et al: Enhanced angio-genesis and growth of collaterals by in vivo admini-stration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor. J. Vasc. Surg. (1992) 16:181–191.
   PubMed Web of Science ®Google Scholar
• •Well-controlled analysis of the angiogenic effects of bFGF in a rabbit model of limb ischaemia.
   Google Scholar
• CHLEBOUN JO, MARTINS RN: The development and en-hancement of the collateral circulation in an animal model of lower limb ischaemia. Aust. NZ. J. Surg. (1994) 64:202–207.
   PubMedGoogle Scholar
• ASAHARA T, BAUTERS C, ZHENG LP et al.: Synergistic ef-fect of vascular endothelial growth factor and basic fi-broblast growth factor on angiogenesis in vivo. Circulation (1995) 92:11365–371.
   Google Scholar
• GOTO F, GOTO K, WEINDEL K, FOLKMAN J: Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels [see comments]. Lab. Invest. (1993) 69:508–517.
   PubMed Web of Science ®Google Scholar
• PEPPER MS, FERRARA N, ORCI L, MONTESANO R: Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem. Biophys. Res. Commun. (1992) 189:824–831.
   PubMed Web of Science ®Google Scholar
• YANAGISAWA-MIWA A, UCHIDA Y, NAKAMURA F et al: Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science (1992) 257:1401–1403.
   PubMed Web of Science ®Google Scholar
• ••Important manuscript demonstrating the positive effects ofbFGF on coronary circulation through an angiogenic mechanism.
   Google Scholar
• BATTLER A, SCHEINOWITZ M, BOR A et al.: Intracoro-nary injection of basic fibroblast growth factor en-hances angiogenesis in infarcted swine myocardium. J. Am. Coll. Cardiol (1993) 22:2001–2006.
   PubMed Web of Science ®Google Scholar
• UNGER EF, BANAI S, SHOU M et al.: Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am. J. Physiol. (1994) 266:H1588–H1595.
   PubMed Web of Science ®Google Scholar
• SELLKE FW, WANG SY, FRIEDMAN M et al.: Basic FGF en-hances endothelium-dependent relaxation of the collateral-perfused coronary microcirculation. Am. J. Physiol. (1994) 267:H1303–H1311.
   Google Scholar
• HARADA K, GROSSMAN W, FRIEDMAN M et al.: Basic fi-broblast growth factor improves myocardial function in chronically ischemic porcine hearts. J. Clin. Invest. (1994) 94:623–630.
   PubMed Web of Science ®Google Scholar
• HORRIGAN MC, MACISAAC Al, NICOLINI FA et al.: Reduc-tion in myocardial infarct size by basic fibroblast growth factor after temporary coronary occlusion in a canine model. Circulation (1996) 94:1927–1933.
   PubMedGoogle Scholar
• MIYATAKA M, ISHIKAWA K, KATORI R: Basic fibroblast growth factor increased regional myocardial blood flow and limited infarct size of acutely infarcted myo-cardium in dogs. Angiology (1998) 49:381–390.
   PubMedGoogle Scholar
• SCHUMACHER B, PECHER P, VON SPECHT BU, STEG-MANN T: Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease [see comments]. Circulation (1998) 97:645–650.
   PubMed Web of Science ®Google Scholar
• •First clinical trial of bFGF in coronary bypass patients dem-onstrating angiogenic activity and increased blood flow.
   Google Scholar
• MEURICE T, BAUTERS C, AUFFRAY JL et al.: Basic fibro-blast growth factor restores endothelium-dependent responses after balloon injury of rabbit arteries. Circu-lation (1996) 93:18–22.
   PubMedGoogle Scholar
• MEURICE T, BAUTERS C, VALLET B et al.: bFGF restores endothelium-dependent responses of hypercholes-terolemic rabbit thoracic aorta. Am. J. Physiol. (1997) 272:H613–H617.
   Google Scholar
• THE FIBLAST® SAFETY STUDY GROUP: Clinical safety trial of intravenous basic fibroblast growth factor (bFGF, FIBLAST®) in acute stroke. Stroke (1998) 29:287.
   Google Scholar
• •First report of Phase I studies of bFGF in stroke patients.
   Google Scholar
• SMALLWOOD PM, MUNOZ-SANJUAN I, TONG P et al: Fi-broblast growth factor (FGF) homologous factors: new members of the FGF family implicated in nervous sys-tem development. Proc. Natl. Acad. ScL USA (1996) 93:9850–9857.
   PubMed Web of Science ®Google Scholar
• YAO D-L, MASONIC K, PETULLO D et al.: Pretreatment with intravenous FGF-13 reduced infarct size and ame-liorates neurological deficits following focal cerebral ischemia in rats. Soc. Neurosci. Abstr. (1997) 23:2439.
   Google Scholar
• LIU Z, HOMES GL: Basic fibroblast growth factor is highly neuroprotective against seizure-induced long-term behavioral deficits. Neuroscience (1997) 76:1129–1138.
   PubMed Web of Science ®Google Scholar
• CUEVAS P, CARCELLER F, MUNOZ-WILLERY I, GIMENEZ-GALLEGO G: Intravenous fibroblast growth factor penetrates the blood-brain barrier and protects hippo-campal neurons against ischemia-reperfusion injury. Surg. Neurol (1998) 49:77–84.
   PubMedGoogle Scholar
• •Indication of potential active transport of bFGF across the blood-brain barrier.
   Google Scholar
• CUEVAS P, FERNANDEZ-AYERDI A, CARCELLER F et al: Central nervous system distribution of fibroblast growth factor injected into the blood stream. Neurol. Res. (1996) 16:267–272.
   Google Scholar
• •Indication of potential active transport of bFGF across the blood-brain barrier.
   Google Scholar
• WAGNER JP, BLACK IB, DICICCO-BLOOM E: Selective transfer of basic fibroblast growth factor (bFGF) across the mature blood brain barrier. Soc. Neurosci. Abstracts (1996) 22:522.
   Google Scholar
• •Indication of potential active transport of bFGF across the blood-brain barrier.
   Google Scholar